Navigation Links
Biotechnology: Global Industry Guide
Date:1/8/2013

bishi Tanabe Pharma Corporation: key financials (¥) 217

Table 147: Mitsubishi Tanabe Pharma Corporation: key financial ratios 217

Table 148: AstraZeneca PLC: key facts 219

Table 149: AstraZeneca PLC: key financials ($) 220

Table 150: AstraZeneca PLC: key financial ratios 220

Table 151: Boehringer Ingelheim GmbH: key facts 222

Table 152: Boehringer Ingelheim GmbH: key financials ($) 223

Table 153: Boehringer Ingelheim GmbH: key financials (€) 223

Table 154: Boehringer Ingelheim GmbH: key financial ratios 223

Table 155: BioAlliance Pharma SA: key facts 225

Table 156: bioMerieux SA: key facts 226

Table 157: bioMerieux SA: key financials ($) 227

Table 158: bioMerieux SA: key financials (€) 227

Table 159: bioMerieux SA: key financial ratios 227

Table 160: Transgene S.A.: key facts 229

Table 161: Transgene S.A.: key financials ($) 230

Table 162: Transgene S.A.: key financial ratios 230

Table 163: MorphoSys AG: key facts 232

Table 164: MorphoSys AG: key financials ($) 233

Table 165: MorphoSys AG: key financials (€) 233

Table 166: MorphoSys AG: key financial ratios 233

Table 167: Gentium S.p.A.: key facts 235

Table 168: Gentium S.p.A.: key financials ($) 236

Table 169: Gentium S.p.A.: key financials (€) 236

Table 170: Gentium S.p.A.: key financial ratios 236

Table 171: Menarini Group, The: key facts 238

Table 172: Zambon Company S.p.A.: key facts 239

Table 173: Daiichi Sankyo Co., Ltd.: key facts 240

Table 174: Daiichi Sankyo Co., Ltd.: key financials ($) 241

Table 175: Daiichi Sankyo Co., Ltd.: key financials (¥) 241

Table 176: Daiichi Sankyo Co., Ltd.: key financial ratios 241

Table 177: Novartis AG: key facts 243

Table 178: Novartis AG: key financials ($) 244

Table 179: Novartis AG: key financial ratios 244


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. WCCT Global (WCCT) & Verified Clinical Trials (VCT) Announce Medication Adherence Documentation Capabilities Have Been Added to the VCT Clinical Trials Database Registry
2. Lucintel’s Analysis of the Global Glass Mat Thermoplastics Industry: Market is Expected to Reach US $481 Million in 2017
3. Lucintel Performs Competitive Analysis on Top Five Global Consumer Electronic Companies
4. Global Pre-Clinical Imaging Market Analyzed & Forecast by MarketsandMarkets in Report Now Available at MarketPublishers.com
5. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
6. ISPE Announces 2012 Award Winners at Global Annual Meeting
7. Global Agricultural Biotechnology Industry
8. Global Membrane Bioreactor (MBR) Systems Market Worth $2,052 Million by 2017
9. BioNeutral Group Receives Positive Testing Results From A Global Independent Laboratory For Its Ygiene Sterilant Against Anthrax Spores
10. Chemotherapy Induced Nausea and Vomiting (CINV) Existing and Pipeline Drugs Market is Expected to Reach USD 2.1 Billion Globally in 2018: Transparency Market Research
11. Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015  Scientists from the J. ... organization, published a paper today outlining new synthetic ... called diatoms. The researchers, led by first author ... Philip Weyman , Ph.D., conclude that these ... of diatom genetics and thus facilitate advances in ...
(Date:4/21/2015)... , April 21, 2015 Merrimack Pharmaceuticals, ... from a multi-arm Phase 1 study of MM-141, a ... presented in an oral session by Dr. Mansoor ... Cancer Research Annual Meeting in Philadelphia, PA. ... of MM-141 as a monotherapy and in combination with ...
(Date:4/21/2015)... -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced ... April 23, 4:30 p.m. ET. Participants are invited to ... Investor call information: U.S./ Canada ... (925) 418-7845 Participant Passcode: 32888538 Questions can ... tina.amirkiai@fleishman.com . Access will be provided ...
(Date:4/21/2015)... 21, 2015  Cryoport, Inc. (OTCBB: CYRX) ... logistics solutions for the life sciences industry, ... lines, clinical research organizations, vaccine manufacturers and ... Mark W. Sawicki , Chief Commercial Officer, ... Summit in San Francisco, CA ...
Breaking Biology Technology:Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Ampio Announces Investor Call on Thursday, April 23, 4:30 p.m. ET 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 3
... Oct. 29 Vical Incorporated,(Nasdaq: VICL ) today ... three months and nine months ended September 30, 2008,before ... conduct a,conference call and webcast to discuss the financial ... on Wednesday, November 5. The call is,open on a ...
... Clearance from ... Development Progress Triggered $1M Milestone Payment from Cook Medical - ... 4:30 p.m. Eastern Time -, REDWOOD CITY, Calif., October 28 ... its fiscal 2009 first quarter ended September 30, 2008., "We had ...
... $490 Million, Up 14 Percent over Third Quarter 2007 ... Sales and Earnings Guidance, Introduces 2009 Adjusted Net ... Oct. 28 Cephalon, Inc. (Nasdaq:,CEPH) today reported third quarter ... for the third quarter of 2007, and at the high,end ...
Cached Biology Technology:Vical Announces News Release and Conference Call Schedule For Third Quarter 2008 Financial Results 2Vical Announces News Release and Conference Call Schedule For Third Quarter 2008 Financial Results 3Cardica Announces Fiscal 2009 First Quarter Financial Results 2Cardica Announces Fiscal 2009 First Quarter Financial Results 3Cardica Announces Fiscal 2009 First Quarter Financial Results 4Cardica Announces Fiscal 2009 First Quarter Financial Results 5Cardica Announces Fiscal 2009 First Quarter Financial Results 6Cephalon Reports Another Strong Quarter 2Cephalon Reports Another Strong Quarter 3Cephalon Reports Another Strong Quarter 4Cephalon Reports Another Strong Quarter 5Cephalon Reports Another Strong Quarter 6Cephalon Reports Another Strong Quarter 7Cephalon Reports Another Strong Quarter 8Cephalon Reports Another Strong Quarter 9Cephalon Reports Another Strong Quarter 10Cephalon Reports Another Strong Quarter 11Cephalon Reports Another Strong Quarter 12Cephalon Reports Another Strong Quarter 13Cephalon Reports Another Strong Quarter 14Cephalon Reports Another Strong Quarter 15Cephalon Reports Another Strong Quarter 16Cephalon Reports Another Strong Quarter 17Cephalon Reports Another Strong Quarter 18Cephalon Reports Another Strong Quarter 19
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:4/14/2015)... NEW YORK , April 14, 2015 /PRNewswire/ ... Fast IDentity Online (FIDO ® ) Alliance tm ... standards-based specifications. FIDO members commit to share technology ... authentication methods that are interoperable, more secure and ... specifications enable biometric identity verification that protects sensitive ...
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... researchers have discovered a novel molecular mechanism that can ... progression of some cancers. In the March 23 online ... scientists from the University of Montreal explain how they ... of inflammatory cytokines that normally activate the immune system, ...
... diagnosis is critical in treating Lyme disease. However, ... initially misdiagnosed because currently available serological tests have ... of infection. Misdiagnosed patients may go untreated and ... face longer and more invasive treatments, as well ...
... National Renewable Energy Laboratory (NREL) recently convened the ... with a mission to enable securitization of solar ... marketplace. SAPC,s primary efforts center on the ... documents relevant to residential and commercial deployment, and ...
Cached Biology News:University of Montreal researchers discover how drug prevents aging and cancer progression 2Penn Researchers attach Lyme disease antibodies to nanotubes, paving way for diagnostic device 2Penn Researchers attach Lyme disease antibodies to nanotubes, paving way for diagnostic device 3Penn Researchers attach Lyme disease antibodies to nanotubes, paving way for diagnostic device 4NREL assembles industry working group to advance solar securitization 2
5,6 Carboxyfluorescein is conjugated to BSA (bovine serum albumin) protein through amide bonds....
2,4,6-Trinitrophenyl hapten is conjugated to Bovine Serum Albumin protein through lysine by amide bonds....
... Edwards (1996) • Provides key ... immunoassays, including RIA, ELISA and ... the photoluminescent and chemiluminescent labels ... also given on assay design ...
EoProbe Eosinophil Staining Kit, 1 Kit...
Biology Products: